Global Leading Market Research Publisher QYResearch announces the release of its latest report "Feed β-Glucanase - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Feed β-Glucanase market, including market size, share, demand, industry development status, and forecasts for the next few years.

For feed manufacturers and intensive livestock producers utilizing barley, wheat, and oats in monogastric diets, the presence of β-glucans presents a persistent nutritional challenge—these non-starch polysaccharides increase gut viscosity, impede nutrient absorption, and reduce feed conversion efficiency. The global Feed β-Glucanase market addresses this critical need through specialized exogenous enzymes that degrade β-glucans, mitigating their anti-nutritional effects and unlocking the nutritional potential of cereal-based rations. As global feed costs rise and the industry seeks alternatives to corn and soybean meal, β-glucanase enzymes have become essential tools for enabling cost-effective inclusion of barley and wheat in swine, poultry, and aquaculture feeds.

The global market for Feed β-Glucanase was estimated to be worth US$ 45.83 million in 2025 and is projected to reach US$ 75.21 million, growing at a CAGR of 7.4% from 2026 to 2032. In 2024, global feed β-glucanase production reached 7,120 tons, with an average global market price of US$ 6,010 per ton. This above-average growth rate reflects increasing adoption of β-glucanase as a specialized solution for barley-rich feed formulations, particularly in regions where barley is a cost-competitive cereal alternative.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098209/feed----glucanase

Targeted Enzyme Technology for β-Glucan Degradation
Feed β-glucanase refers to exogenous β-glucan-degrading enzymes produced by fungal or bacterial fermentation. It is a functional enzyme preparation specifically used in the feed industry. Its primary function is to degrade β-glucans, the non-starch polysaccharide components in the cell walls of cereals (such as barley, wheat, and oats), reducing their anti-nutritional effects in the animal digestive tract, thereby improving feed utilization. It is used in monogastric animals such as poultry and pigs, as well as in aquaculture.

The mode of action involves enzymatic hydrolysis of the β-1,3 and β-1,4 glycosidic bonds that form the backbone of β-glucan polymers. By breaking these chains into smaller oligosaccharides and simple sugars, β-glucanase reduces digesta viscosity, liberates encapsulated nutrients, and improves the accessibility of endogenous digestive enzymes. This targeted approach is particularly valuable in barley-based diets, where β-glucan content can reach 4-8% and significantly impair performance without enzyme supplementation.

Industry Segmentation: Distinct Applications Across Species & Production Systems
The Feed β-Glucanase market exhibits distinct application patterns across species, with each presenting unique digestive physiology and formulation requirements:

Poultry (Broilers & Layers): Poultry operations represent the largest application segment, particularly in regions where barley is a primary feed grain. A 5-million-broiler operation in Western Canada recently implemented a β-glucanase-enriched feed program following a shift from corn to locally sourced barley, reporting maintenance of feed conversion ratios (FCR) at 1.65 despite the ingredient change, with estimated annual savings of $450,000 in ingredient costs compared to corn-based formulations.

Swine (Weanling & Grower-Finisher): For swine, β-glucanase application is most critical in weanling diets where immature digestive systems are particularly susceptible to the anti-nutritional effects of cereal β-glucans. The technical challenge involves maintaining enzyme stability through the gastric environment (pH 2-4) while preserving activity in the small intestine where β-glucan degradation is most beneficial. Modern enzyme formulations address this through pH-optimized activity profiles and enteric coating technologies.

Aquaculture (Salmon, Trout, Tilapia): In aquafeeds, β-glucanase enables increased inclusion of wheat and barley byproducts as partial replacements for fishmeal. Carnivorous species such as salmon have limited capacity to digest plant cell wall polysaccharides, making exogenous enzyme supplementation essential for maintaining digestibility coefficients. Recent trials in Norwegian salmon feeds have demonstrated that β-glucanase supplementation can improve protein digestibility by 5-8% in diets containing 20% wheat-based ingredients.

Upstream Supply Chain & Production Technology
From an upstream and downstream supply perspective, the upstream sector includes suppliers of the microbial strains required for production (such as genetically engineered strains of Trichoderma reesei and Aspergillus niger) and fermentation raw materials (such as carbon and nitrogen sources like corn starch and soybean meal). The midstream sector comprises enzyme manufacturers, and the downstream end-users are large-scale feed producers and integrated livestock operations, which add complex enzyme products containing β-glucanase to premixes and complete feeds.

Recent advancements in strain engineering have improved production economics. Over the past six months, several manufacturers have announced the commercialization of high-yield Aspergillus niger strains achieving β-glucanase activity levels 40% higher than previous commercial strains, reducing production costs and enabling more competitive pricing. Additionally, the development of granular thermostable formulations has addressed a historical technical difficulty: maintaining β-glucanase activity through the feed pelleting process, where conventional liquid enzymes can be heat-labile at temperatures above 70°C.

Regional Market Dynamics & Policy Drivers
Over the past six months, several regulatory and market developments have accelerated adoption. The European Union's updated Feed Additives Regulation has recognized β-glucanase as a key enabling technology for reducing the carbon footprint of livestock production by facilitating use of locally grown cereals. In Canada, the federal government's "Barley Utilization Initiative" continues to promote enzyme technologies that enable increased barley inclusion in monogastric feeds, supporting domestic grain markets.

Regionally, North America and Europe maintain the highest penetration rates, driven by established barley-growing regions and mature feed enzyme markets. The Asia-Pacific region represents the fastest-growing market, with expanding intensive livestock production in China and Southeast Asia creating demand for enzyme solutions that improve feed efficiency and reduce reliance on imported corn and soybean meal.

Competitive Landscape and Strategic Positioning
The market comprises established multinational enzyme producers alongside specialized regional manufacturers. Key players include Novozymes, AB Enzymes, DSM-Firmenich, Aum Enzymes, BASF, Kemin Industries, Creative Biogene, Guangdong Vtr Bio-Tech, Wuhan Sunhy Biology, Fuda Biotech, Sunson Industry Group, Beijing Strowin Biotechnology (BSB), Shandong Sukahan Bio-Technology, and Qingdao Vland Biotech. A notable trend is the consolidation of β-glucanase into multi-enzyme cocktails that combine xylanase, cellulase, and other NSP-degrading activities, offering feed manufacturers simplified inventory management and synergistic performance benefits.

Market Segmentation
The Feed β-Glucanase market is segmented as below:

By Company

Novozymes

AB Enzymes

DSM-Firmenich

Aum Enzymes

BASF

Kemin Industries

Creative Biogene

Guangdong Vtr Bio-Tech

Wuhan Sunhy Biology

Fuda Biotech

Sunson Industry Group

Beijing Strowin Biotechnology (BSB)

Shandong Sukahan Bio-Technology

Qingdao Vland Biotech

Segment by Type

Acidic

Neutral

Segment by Application

Swine

Poultry

Aquaculture

Others

Exclusive Industry Outlook
Looking ahead, the convergence of β-glucanase technology with precision nutrition platforms represents a significant growth frontier. Emerging analytical tools enable feed manufacturers to measure β-glucan content in incoming cereal batches in real-time, allowing dynamic adjustment of enzyme inclusion rates to match raw material variability—optimizing cost efficiency while ensuring consistent performance. Additionally, research into the prebiotic effects of β-glucan degradation products is revealing that enzyme-generated oligosaccharides may stimulate beneficial gut microbiota, adding a functional nutrition dimension beyond simple digestibility improvement. The ability to offer β-glucanase formulations optimized for specific cereal types, species, and production stages—supported by analytical services and performance guarantees—will define competitive differentiation in the coming market cycle.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp